Investors pour record money worth over Rs 10,000 cr in flexicap MFs in December. Time to add or rebalance?

Flexicap mutual funds saw record inflows of over Rs 10,000 crore in December. This surge highlights investor confidence in ...

Investors Will Want Vp's (LON:VP.) Growth In ROCE To Persist

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want ...
AMBCrypto

Assessing PEPE’s pullback after an 80% surge – Levels to watch are…

Given the surge in capital flow at the start of January, a retracement back below the $0.0000044-$0.00000050 demand zone ...

Nature Communications reports promising effect of Idorsia’s lucerastat on kidney function in Fabry disease

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying ...

Sanofi: Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes

Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D ...

Idorsia Pharmaceuticals Ltd: Nature Communications reports promising effect of Idorsia's lucerastat on kidney function in Fabry disease

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying e ...